Attribution Statement: LactMed is a registered trademark of the U.S. Department of Health and Human Services.
NCBI Bookshelf. A service of the National Library of Medicine, National Institutes of Health.
Drugs and Lactation Database (LactMed®) [Internet]. Bethesda (MD): National Institute of Child Health and Human Development; 2006-.
CASRN: 188627-80-7
Drug Levels and Effects
Summary of Use during Lactation
No published information is available on the use of eptifibatide during breastfeeding. Because eptifibatide is a peptide, absorption by the infant is unlikely because it is probably destroyed in the infant's gastrointestinal tract. Until more data become available, eptifibatide should be used with caution during breastfeeding, especially while nursing a newborn or preterm infant. If it is used by a nursing mother, monitor the infant for bruising and bleeding.
Drug Levels
Maternal Levels. Relevant published information was not found as of the revision date.
Infant Levels. Relevant published information was not found as of the revision date.
Effects in Breastfed Infants
Relevant published information was not found as of the revision date.
Effects on Lactation and Breastmilk
Relevant published information was not found as of the revision date.
Alternate Drugs to Consider
Substance Identification
Substance Name
Eptifibatide
CAS Registry Number
188627-80-7
Drug Class
- Breastfeeding
- Platelet Aggregation Inhibitors
Disclaimer: Information presented in this database is not meant as a substitute for professional judgment. You should consult your healthcare provider for breastfeeding advice related to your particular situation. The U.S. government does not warrant or assume any liability or responsibility for the accuracy or completeness of the information on this Site.
- User and Medical Advice Disclaimer
- Drugs and Lactation Database (LactMed) - Record Format
- LactMed - Database Creation and Peer Review Process
- Fact Sheet. Drugs and Lactation Database (LactMed)
- Drugs and Lactation Database (LactMed) - Glossary
- LactMed Selected References
- Drugs and Lactation Database (LactMed) - About Dietary Supplements
- Breastfeeding Links
- PubChem SubstanceRelated PubChem Substances
- Review Liraglutide.[Drugs and Lactation Database (...]Review Liraglutide.. Drugs and Lactation Database (LactMed®). 2006
- Review Exenatide.[Drugs and Lactation Database (...]Review Exenatide.. Drugs and Lactation Database (LactMed®). 2006
- Review Bremelanotide.[Drugs and Lactation Database (...]Review Bremelanotide.. Drugs and Lactation Database (LactMed®). 2006
- Antagonists of platelet fibrinogen receptor are less effective in carriers of Pl(A2) polymorphism of beta(3) integrin.[Eur J Pharmacol. 2002]Antagonists of platelet fibrinogen receptor are less effective in carriers of Pl(A2) polymorphism of beta(3) integrin.Rozalski M, Watala C. Eur J Pharmacol. 2002 Nov 1; 454(1):1-8.
- Review Golimumab.[Drugs and Lactation Database (...]Review Golimumab.. Drugs and Lactation Database (LactMed®). 2006
- Eptifibatide - Drugs and Lactation Database (LactMed®)Eptifibatide - Drugs and Lactation Database (LactMed®)
Your browsing activity is empty.
Activity recording is turned off.
See more...